Identification of serpinb1 as a physiological inhibitor of human granzyme H

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1319-1330

  Wang, Li ^a   Li, Qian ^a   Wu, Lianfeng ^a   Liu, Shengwu ^a   Zhang, Yong ^a   Yang, Xuan ^a   Zhu, Pingping ^a   Zhang, Honglian ^a   Zhang, Kai ^a   Lou, Jizhong ^a   Tong, Liang ^a,b   Sun, Fei ^a,b   Fan, Zusen ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; GRANZYME; GRANZYME H; PHENYLALANINE; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR B1; UNCLASSIFIED DRUG;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; COVALENT BOND; CRYSTAL STRUCTURE; ENZYME CONFORMATION; ENZYME DEGRADATION; ENZYME INHIBITION; GEL FILTRATION CHROMATOGRAPHY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MOLECULAR MODEL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STOICHIOMETRY;

CATALYSIS; CELL LINE, TUMOR; CHROMATOGRAPHY, GEL; CRYSTALLOGRAPHY, X-RAY; CYTOPLASMIC GRANULES; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; GRANZYMES; HUMANS; JURKAT CELLS; KILLER CELLS, LYMPHOKINE-ACTIVATED; MODELS, MOLECULAR; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; RECOMBINANT FUSION PROTEINS; SERPINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84872743281     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202542     Document Type: Article

References (37)

1. Chowdhury, D., and J. Lieberman. 2008. Death by a thousand cuts: Granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26: 389-420. (Pubitemid 351611623)
2. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/ granzyme cell death pathway. Nat. Rev. Immunol. 2: 735-747. (Pubitemid 37328714)
3. Fellows, E., S. Gil-Parrado, D. E. Jenne, and F. C. Kurschus. 2007. Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program. Blood 110: 544-552. (Pubitemid 47105392)
4. Sedelies, K. A., T. J. Sayers, K. M. Edwards, W. Chen, D. G. Pellicci, D. I. Godfrey, and J. A. Trapani. 2004. Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. J. Biol. Chem. 279: 26581-26587. (Pubitemid 38798814)
5. Waterhouse, N. J., and J. A. Trapani. 2007. H is for helper: Granzyme H helps granzyme B kill adenovirus-infected cells. Trends Immunol. 28: 373-375. (Pubitemid 47385378)
6. Hou, Q., T. Zhao, H. Zhang, H. Lu, Q. Zhang, L. Sun, and Z. Fan. 2008. Granzyme H induces apoptosis of target tumor cells characterized by DNA fragmentation and Bid-dependent mitochondrial damage. Mol. Immunol. 45: 1044-1055. (Pubitemid 350016335)
7. Andrade, F., E. Fellows, D. E. Jenne, A. Rosen, and C. S. Young. 2007. Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition. EMBO J. 26: 2148-2157. (Pubitemid 46625785)
8. Romero, V., E. Fellows, D. E. Jenne, and F. Andrade. 2009. Cleavage of La protein by granzyme H induces cytoplasmic translocation and interferes with Lamediated HCV-IRES translational activity. Cell Death Differ. 16: 340-348.
9. Tang, H., C. Li, L. Wang, H. Zhang, and Z. Fan. 2012. Granzyme H of cytotoxic lymphocytes is required for clearance of the hepatitis B virus through cleavage of the hepatitis B virus X protein. J. Immunol. 188: 824-831.
10. Wang, L., K. Zhang, L. Wu, S. Liu, H. Zhang, Q. Zhou, L. Tong, F. Sun, and Z. Fan. 2012. Structural insights into the substrate specificity of human granzyme H: The functional roles of a novel RKR motif. J. Immunol. 188: 765-773.
11. Huntington, J. A. 2011. Serpin structure, function and dysfunction. J. Thromb. Haemost. 9(Suppl. 1): 26-34.
12. Zhang, M., S. M. Park, Y. Wang, R. Shah, N. Liu, A. E. Murmann, C. R. Wang, M. E. Peter, and P. G. Ashton-Rickardt. 2006. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 24: 451-461.
13. de Koning, P. J., J. A. Kummer, S. A. de Poot, R. Quadir, R. Broekhuizen, A. F. McGettrick,W. J. Higgins, B. Devreese, D. M. Worrall, and N. Bovenschen. 2011. Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death. PLoS ONE 6: E22645.
14. Hua, G., Q. Zhang, and Z. Fan. 2007. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme Mmediated apoptosis. J. Biol. Chem. 282: 20553-20560. (Pubitemid 47100029)
15. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326. (Pubitemid 27085611)
16. Read, R. J. 2001. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D Biol. Crystallogr. 57: 1373-1382. (Pubitemid 36117185)
17. Emsley, P., and K. Cowtan. 2004. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126-2132. (Pubitemid 41742764)
18. Laskowski, R. A., J. A. Rullmannn, M. W. MacArthur, R. Kaptein, and J. M. Thornton. 1996. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8: 477-486. (Pubitemid 126706801)
19. Eswar, N., B. Webb, M. A. Marti-Renom, M. S. Madhusudhan, D. Eramian, M.-y. Shen, U. Pieper, and A. Sali. 2006. Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics 15: 5.6.1-5.6.30.
20. Huntington, J. A., R. J. Read, and R. W. Carrell. 2000. Structure of a serpinprotease complex shows inhibition by deformation. Nature 407: 923-926.
21. Dementiev, A., J. Dobó, and P. G. Gettins. 2006. Active site distortion is sufficient for proteinase inhibition by serpins: Structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase. J. Biol. Chem. 281: 3452-3457. (Pubitemid 43845960)
22. Phillips, J. C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C. Chipot, R. D. Skeel, L. Kalé, and K. Schulten. 2005. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26: 1781-1802. (Pubitemid 43078511)
23. Case, D. A., T. A. Darden, T. E. CheathamIII, C. L. Simmerling, J.Wang, R. E. Duke, R. Luo, R. C. Walker, W. Zhang, K. M. Merz, et al. 2012. AMBER 12. University of California San Francisco, San Francisco, CA. Available at: Http://ambermd.org/.
24. Casey, T. M., J. L. Meade, and E. W. Hewitt. 2007. Organelle proteomics: Identification of the exocytic machinery associated with the natural killer cell secretory lysosome. Mol. Cell. Proteomics 6: 767-780. (Pubitemid 46831930)
25. Cooley, J., T. K. Takayama, S. D. Shapiro, N. M. Schechter, and E. Remold-O'Donnell. 2001. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 40: 15762-15770. (Pubitemid 34015205)
26. Fan, Z., P. J. Beresford, D. Y. Oh, D. Zhang, and J. Lieberman. 2003. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112: 659-672. (Pubitemid 36331778)
27. Edwards, K. M., C. M. Kam, J. C. Powers, and J. A. Trapani. 1999. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes. J. Biol. Chem. 274: 30468-30473.
28. Silverman, G. A., P. I. Bird, R. W. Carrell, F. C. Church, P. B. Coughlin, P. G. Gettins, J. A. Irving, D. A. Lomas, C. J. Luke, R. W. Moyer, et al. 2001. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276: 33293-33296.
29. Schechter, I., and A. Berger. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27: 157-162.
30. Ye, S., A. L. Cech, R. Belmares, R. C. Bergstrom, Y. Tong, D. R. Corey, M. R. Kanost, and E. J. Goldsmith. 2001. The structure of a Michaelis serpinprotease complex. Nat. Struct. Biol. 8: 979-983.
31. Baglin, T. P., R. W. Carrell, F. C. Church, C. T. Esmon, and J. A. Huntington. 2002. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. USA 99: 11079-11084. (Pubitemid 34920882)
32. Benarafa, C., and E. Remold-O'Donnell. 2005. The ovalbumin serpins revisited: Perspective from the chicken genome of clade B serpin evolution in vertebrates. Proc. Natl. Acad. Sci. USA 102: 11367-11372. (Pubitemid 41153826)
33. Benarafa, C., G. P. Priebe, and E. Remold-O'Donnell. 2007. The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J. Exp. Med. 204: 1901-1909. (Pubitemid 47236325)
34. Benarafa, C., T. E. LeCuyer, M. Baumann, J. M. Stolley, T. P. Cremona, and E. Remold-O'Donnell. 2011. SerpinB1 protects the mature neutrophil reserve in the bone marrow. J. Leukoc. Biol. 90: 21-29.
35. Remold-O'Donnell, E., J. Chin, and M. Alberts. 1992. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc. Natl. Acad. Sci. USA 89: 5635-5639.
36. Cooley, J., M. K. Sontag, F. J. Accurso, and E. Remold-O'Donnell. 2011. SerpinB1 in cystic fibrosis airway fluids: Quantity, molecular form and mechanism of elastase inhibition. Eur. Respir. J. 37: 1083-1090.
37. Davies, P. L., O. B. Spiller, M. L. Beeton, N. C. Maxwell, E. Remold-O'Donnell, and S. Kotecha. 2010. Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity. Thorax 65: 246-251.